The Oncology Institute Appoints Kim Tzoumakas to Board of Directors

Core Insights - The Oncology Institute, Inc. has appointed Kim Tzoumakas to its Board of Directors, effective February 23, 2026, bringing over 20 years of executive leadership experience in oncology and healthcare operations [1][2] - Tzoumakas has a notable background, including her role as CEO of VytlOne National Pharmacy Services and previous leadership at 21st Century Oncology, where she led a successful operational turnaround [1][2] - The appointment is seen as timely as TOI expands its care delivery model and pharmacy business, with Tzoumakas's experience expected to enhance access, cost management, and integrated care delivery [2] Company Overview - The Oncology Institute, founded in 2007, is a leading provider of value-based cancer care in the community setting, serving approximately 1.9 million patients [3] - TOI operates over 100 clinics and affiliate locations across five states, employing more than 180 clinicians, and is focused on advancing oncology through specialized, evidence-based care [3]